文献速递类风湿关节炎脊柱关节炎

银屑病关节炎与类风湿关节炎患者的健康相关生活质量:来自前瞻性多中心NOR-DMARD研究的数据与挪威一般人群对照比较

Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.
PubMed 文献 · Ann Rheum Dis · 2018-06-06

基于前瞻性多中心NOR-DMARD研究(随访6个月),比较首次入组的类风湿关节炎(RA,n=3898)与银屑病关节炎(PsA,n=1515)患者及挪威一般人群对照(n=2323)的SF-36各维度及SF-6D。年龄性别校正后PsA与RA的PCS、MCS、SF-6D相似(p≥0.14);进一步校正28关节疾病活动评分后PsA的PCS、多数维度及SF-6D劣于RA(p≤0.01);两组PCS损害均重于MCS(p≤0.001);RA在躯体疼痛、活力、心理健康方面3个月和6个月改善大于PsA(p≤0.02)。

要点

  • 年龄性别校正后PsA与RA的PCS、MCS、SF-6D相似(p≥0.14)。
  • 校正28关节疾病活动评分后PsA的PCS、多数维度及SF-6D劣于RA(p≤0.01)。
  • RA在躯体疼痛、活力、心理健康方面3个月和6个月改善大于PsA(p≤0.02)。

核心结论

  • RA与PsA患者的健康相关生活质量总体相似,PsA有更差的趋势,且均差于挪威一般人群对照。

研究设计与样本

  • 前瞻性观察性多中心NOR-DMARD研究,随访6个月,首次入组RA患者n=3898、PsA患者n=1515,挪威一般人群对照n=2323,采用协方差分析比较SF-36各维度及SF-6D。

主要发现

  • 年龄性别校正后,PsA与RA的PCS、MCS、SF-6D相似(p≥0.14),PsA活力与总体健康更差、躯体功能更好(0/6个月,p≤0.03)。
  • 进一步校正28关节疾病活动评分后,PsA的PCS、多数维度评分及SF-6D在0/3/6个月均劣于RA(p≤0.01)。
  • 与一般人群对照相比,RA和PsA的PCS损害均重于MCS(p≤0.001)。
  • 改善抗风湿药治疗后3个月和6个月,RA在躯体疼痛、活力、心理健康方面的平均改善大于PsA(p≤0.02)。

关键数值与推荐

  • 年龄性别校正后PsA vs RA的PCS、MCS、SF-6D差异无统计学意义(p≥0.14)。
  • 校正28关节疾病活动评分后PsA vs RA的PCS、多数维度及SF-6D更差(p≤0.01)。
  • RA和PsA vs 一般人群对照的PCS损害重于MCS(p≤0.001)。
  • RA vs PsA的3个月和6个月躯体疼痛、活力、心理健康平均改善更大(p≤0.02)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare (1) Short Form-36 (SF-36) Physical Component Summary (PCS) and Mental Component Summary (MCS), scale scores and Short Form-6 dimensions (SF-6D) between patients with rheumatoid arthritis (RA) and patients with psoriatic arthritis (PsA) and Norwegian general population controls and (2) improvements in these measures between patients with RA and PsA. METHODS: Analyses of covariance were performed to compare SF-36 measures between first-time enrolled patients with RA (n=3898) and PsA (n=1515) from the prospective observational multicentre NORwegian-Disease Modifying Anti-Rheumatic Drug study (6 months follow-up) and general population controls (n=2323). RESULTS: In age and gender-adjusted analyses, patients with PsA compared with patients with RA had similar PCS, MCS and SF-6D (p≥0.14), worse vitality and general health, but better physical functioning at 0/6 months (p≤0.03). With additional 28-joint disease activity scores adjustment as a proxy for joint inflammation, PCS, most scale scores and SF-6D were worse in patients with PsA than patients with RA at 0/3/6 months (p≤0.01). PCS was more impaired than MCS both in RA and PsA compared with general population controls (p≤0.001). Mean 3-month and 6-month improvements after disease-modifying anti-rheumatic drug treatment were larger in patients with RA than patients with PsA for bodily pain, vitality and mental health (p≤0.02). CONCLUSIONS: Health-related quality of life was overall similar in patients with RA and patients with PsA-with a tendency to worse scores in PsA-and worse compared with Norwegian general population controls.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Michelsen B, Uhlig T, Sexton J, et al. Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Ann Rheum Dis. 2018. PMID: 29875096. doi:10.1136/annrheumdis-2018-213286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。